{"id":"tyloxapol","rwe":[{"pmid":"41744101","year":"2026","title":"In vivo evaluation of hypolipidaemic and antioxidant effects of aqueous extract from Caco seeds (Chrysobalanus icaco L.) and action mechanisms by in silico prediction in a model of hypertriglyceridaemia.","finding":"","journal":"The British journal of nutrition","studyType":"Clinical Study"},{"pmid":"41688985","year":"2026","title":"Efficacy and safety of mucolytic agents in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis.","finding":"","journal":"BMC pulmonary medicine","studyType":"Clinical Study"},{"pmid":"41676709","year":"2026","title":"Tyloxapol inhibits ESX-1 secretion in Mycobacterium marinum.","finding":"","journal":"bioRxiv : the preprint server for biology","studyType":"Clinical Study"},{"pmid":"41465421","year":"2025","title":"The Disruption of Cyp7b1 Controls IGFBP2 and Prediabetes Exerted Through Different Hydroxycholesterol Metabolites.","finding":"","journal":"International journal of molecular sciences","studyType":"Clinical Study"},{"pmid":"41345258","year":"2025","title":"AMPK affects the development of early-stage NAFLD by activating autophagy and fatty acid oxidation.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"}],"tags":[{"label":"tyloxapol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R05CA01","category":"atc"},{"label":"Active","category":"status"},{"label":"Respiratory distress syndrome in the newborn","category":"indication"},{"label":"Glaxosmithkline","category":"company"},{"label":"Approved 1990s","category":"decade"},{"label":"Detergents","category":"pharmacology"},{"label":"Surface-Active Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"GSK","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=TYLOXAPOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:22:50.307436+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Tyloxapol","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T03:22:57.382819+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:22:56.041342+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TYLOXAPOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:22:56.325923+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201548/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:22:57.033148+00:00"}},"allNames":"alevaire","offLabel":[],"synonyms":["tyloxapol","alevaire"],"timeline":[{"date":"1990-08-02","type":"positive","source":"DrugCentral","milestone":"FDA approval (Glaxosmithkline)"}],"approvals":[{"date":"1990-08-02","orphan":false,"company":"GLAXOSMITHKLINE","regulator":"FDA"}],"brandName":"Alevaire","ecosystem":[{"indication":"Respiratory distress syndrome in the newborn","otherDrugs":[{"name":"beractant","slug":"beractant","company":"Abbvie"},{"name":"calfactant","slug":"calfactant","company":"Ony"},{"name":"cetyl alcohol","slug":"cetyl-alcohol","company":"Glaxosmithkline"},{"name":"colfosceril palmitate","slug":"colfosceril-palmitate","company":"Glaxosmithkline"}],"globalPrevalence":null}],"mechanism":{"novelty":"Follow-on","modality":"Small Molecule","drugClass":"tyloxapol","explanation":"","oneSentence":"","technicalDetail":"Alevaire is a surfactant replacement therapy that works by reducing the surface tension in the lungs, thereby improving lung compliance and gas exchange."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Tyloxapol","title":"Tyloxapol","extract":"Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen."},"commercial":{"launchDate":"1990","_launchSource":"DrugCentral (FDA 1990-08-02, GLAXOSMITHKLINE)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4738","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=TYLOXAPOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TYLOXAPOL","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Tyloxapol","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T16:10:50.826435","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:22:58.677339+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"potassium iodide","drugSlug":"potassium-iodide","fdaApproval":"1979-11-09","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"guaifenesin","drugSlug":"guaifenesin","fdaApproval":"2002-07-12","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cineole","drugSlug":"cineole","fdaApproval":"","relationship":"same-class"}],"genericName":"tyloxapol","indications":{"approved":[{"name":"Respiratory distress syndrome in the newborn","source":"DrugCentral","snomedId":46775006,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"potassium-iodide","brandName":"potassium iodide","genericName":"potassium iodide","approvalYear":"1979","relationship":"same-class"},{"drugId":"guaifenesin","brandName":"guaifenesin","genericName":"guaifenesin","approvalYear":"2002","relationship":"same-class"},{"drugId":"cineole","brandName":"cineole","genericName":"cineole","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07432373","phase":"","title":"Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection","status":"NOT_YET_RECRUITING","sponsor":"National University of Malaysia","startDate":"2026-04-01","conditions":["Pleural Infection"],"enrollment":80,"completionDate":"2028-07-01"},{"nctId":"NCT01203358","phase":"PHASE2,PHASE3","title":"Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"1991-01","conditions":["Infant, Newborn","Infant, Low Birth Weight","Infant, Small for Gestational Age","Infant, Premature","Bronchopulmonary Dysplasia"],"enrollment":617,"completionDate":"1992-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000179276","MMSL":"5650","NDDF":"000719","UNII":"Y27PUL9H56","VUID":"4019371","CHEBI":"CHEBI:141517","VANDF":"4019371","INN_ID":"1435","RXNORM":"38998","UMLSCUI":"C0077539","chemblId":"CHEMBL1201548","ChEMBL_ID":"CHEMBL1201548","KEGG_DRUG":"D03261","DRUGBANK_ID":"DB06439","PUBCHEM_CID":"71388","SNOMEDCT_US":"108888009","MESH_SUPPLEMENTAL_RECORD_UI":"C016811"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1990-","companyName":"GSK","relationship":"Original Developer"}],"publicationCount":200,"therapeuticAreas":["Respiratory"],"atcClassification":{"source":"DrugCentral","atcCode":"R05CA01","allCodes":["R05CA01"]},"biosimilarFilings":[],"originalDeveloper":"Glaxosmithkline","recentPublications":[{"date":"2026 Feb 26","pmid":"41744101","title":"In vivo evaluation of hypolipidaemic and antioxidant effects of aqueous extract from Caco seeds (Chrysobalanus icaco L.) and action mechanisms by in silico prediction in a model of hypertriglyceridaemia.","journal":"The British journal of nutrition"},{"date":"2026 Feb 13","pmid":"41688985","title":"Efficacy and safety of mucolytic agents in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis.","journal":"BMC pulmonary medicine"},{"date":"2026 Feb 2","pmid":"41676709","title":"Tyloxapol inhibits ESX-1 secretion in Mycobacterium marinum.","journal":"bioRxiv : the preprint server for biology"},{"date":"2025 Dec 12","pmid":"41465421","title":"The Disruption of Cyp7b1 Controls IGFBP2 and Prediabetes Exerted Through Different Hydroxycholesterol Metabolites.","journal":"International journal of molecular sciences"},{"date":"2025 Dec 4","pmid":"41345258","title":"AMPK affects the development of early-stage NAFLD by activating autophagy and fatty acid oxidation.","journal":"Scientific reports"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"GSK","companyId":"gsk","modality":"Small Molecule","firstApprovalDate":"1990","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1990-08-02T00:00:00.000Z","mah":"GLAXOSMITHKLINE","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:22:58.677339+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}